ARCHIVES

In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT

This article is from The Cancer Letter archive.

Vol. 22 No. 09 | March 1, 1996

Download PDF Visit The Full Archive

Related Articles

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Dileep Bal Elected Cancer Society President, Young Is President-Elect, Baity Leads Board.

December 8, 2000

Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality

September 18, 1987